Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Expression and function of vascular endothelial growth factor receptor-1 on human colorectal cancer cells

Abstract

Vascular endothelial growth factor (VEGF) is associated with tumor angiogenesis and poor prognosis in human colorectal cancer (CRC). VEGF receptor-1 (VEGFR-1 or Flt-1) is a high-affinity receptor for VEGF and is typically considered specific to endothelial cells. Here we report the expression and function of VEGFR-1 in CRC cell lines. VEGFR-1 was expressed in all CRC cell lines studied as determined by RT–PCR, Western blot analysis, FACS, and ELISA. Treatment of the human CRC cell lines HT-29 and SW480 with VEGF-A (a ligand for both VEGFR-1 and -2) or VEGF-B (a ligand specific for VEGFR-1) led to activation of Erk-1/2, SAPK/JNK, and translocation of the p65 subunit of nuclear factor-κB into the nucleus. Both VEGF-A and -B led to significant induction of cell motility and invasiveness of CRC cells. Stimulation of cells with VEGF-A or -B also led to larger and more numerous colonies in soft agar. However, activation of VEGFR-1 did not increase CRC cell proliferation. In contrast to the previous paradigm that VEGFRs are not present on tumor cells of epithelial origin, we found that VEGFR-1 is present and functional on CRC cells, and activation by VEGF family ligands can activate processes involved in tumor progression and metastasis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, Nguyen HV, Aiello LM, Ferrara N and King GL . (1994). N. Engl. J. Med., 331, 1480–1487.

  • Arora N, Masood R, Zheng T, Cai J, Smith DL and Gill PS . (1999). Cancer Res., 59, 183–188.

  • Bachelder RE, Lipscomb EA, Lin X, Wendt MA, Chadborn NH, Eickholt BJ and Mercurio AM . (2003). Cancer Res., 63, 5230–5233.

  • Barleon B, Sozzani S, Zhou D, Weich H, Mantovani A and Marme D . (1996). Blood, 87, 3336–3343.

  • Bellamy WT, Richter L, Frutiger Y and Grogan TM . (1999). Cancer Res., 59, 728–733.

  • Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Senger DR and Dvorak HF . (1993). Cancer Res., 53, 4727–4735.

  • Chen WS, Kitson RP and Goldfarb RH . (2002). In Vivo, 16, 439–445.

  • Clauss M, Weich H, Breier G, Knies U, Rockl W, Waltenberger J and Risau W . (1996). J. Biol. Chem., 271, 17629–17634.

  • Detmar M, Brown LF, Claffey KP, Yeo KT, Kocher O, Jackman RW, Berse B and Dvorak HF . (1994). J. Exp. Med., 180, 1141–1146.

  • Dias S, Hattori K, Zhu Z, Heissig B, Choy M, Lane W, Wu Y, Chadburn A, Hyjek E, Gill M, Hicklin DJ, Witte L, Moore MA and Rafii S . (2000). J. Clin. Invest., 106, 511–521.

  • Ferrara N . (1999). Curr. Top. Microbiol. Immunol., 237, 1–30.

  • Ferrara N and Davis-Smyth T . (1997). Endocr. Rev., 18, 4–25.

  • Folkman J . (2001). Semin. Oncol., 28, 536–542.

  • Fong GH, Rossant J, Gertsenstein M and Breitman ML . (1995). Nature, 376, 66–70.

  • Gerber HP, McMurtrey A, Kowalski J, Yan M, Keyt BA, Dixit V and Ferrara N . (1998). J. Biol. Chem., 273, 30336–30343.

  • Hahn D, Simak R, Steiner G, Handisurya A, Susani M and Marberger M . (2000). J. Urol., 164, 506–510.

  • Hasan J and Jayson GC . (2001). Expert Opin. Biol. Ther., 1, 703–718.

  • Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, Berlin J, Baron A, Griffing S, Holmgren E, Ferrara N, Fyfe G, Rogers B, Ross R and Kabbinavar F . (2004). N. Engl. J. Med., 350, 2335–2342.

  • Irrthum A, Karkkainen MJ, Devriendt K, Alitalo K and Vikkula M . (2000). Am. J. Hum. Genet., 67, 295–301.

  • Jung YD, Liu W, Reinmuth N, Ahmad SA, Fan F, Gallick GE and Ellis LM . (2001). Angiogenesis, 4, 155–162.

  • La Rosa S, Uccella S, Finzi G, Albarello L, Sessa F and Capella C . (2003). Hum. Pathol., 34, 18–27.

  • Lalla RV, Boisoneau DS, Spiro JD and Kreutzer DL . (2003). Arch. Otolaryngol. Head Neck Surg., 129, 882–888.

  • LeCouter J, Moritz DR, Li B, Phillips GL, Liang XH, Gerber H-P, Hillan KJ and Ferrara N . (2003). Science, 299, 890–893.

  • Liu W, Ahmad SA, Jung YD, Reinmuth N, Fan F, Bucana CD and Ellis LM . (2002). Cancer, 94, 934–939.

  • Lyden D, Hattori K, Dias S, Costa C, Blaikie P, Butros L, Chadburn A, Heissig B, Marks W, Witte L, Wu Y, Hicklin D, Zhu Z, Hackett NR, Crystal RG, Moore MAS, Hajjar KA, Manova K, Benezra R and Rafii S . (2001). Nat. Med., 7, 1194–1201.

  • Masood R, Cai J, Zheng T, Smith DL, Hinton DR and Gill PS . (2001). Blood, 98, 1904–1913.

  • Mayr-Wohlfart U, Waltenberger J, Hausser H, Kessler S, Gunther KP, Dehio C, Puhl W and Brenner RE . (2002). Bone, 30, 472–477.

  • Olofsson B, Korpelainen E, Pepper MS, Mandriota SJ, Aase K, Kumar V, Gunji Y, Jeltsch MM, Shibuya M, Alitalo K and Eriksson U . (1998). Proc. Natl. Acad. Sci. USA, 95, 11709–11714.

  • Parikh AA, Fan F, Liu WB, Ahmad SA, Stoeltzing O, Reinmuth N, Bielenberg D, Bucana CD, Klagsbrun M and Ellis LM . (2004). Am. J. Pathol., 164, 2139–2151.

  • Patel N, Sun L, Moshinsky D, Chen H, Leahy KM, Le P, Moss KG, Wang X, Rice A, Tam D, Laird AD, Yu X, Zhang Q, Tang C, McMahon G and Howlett A . (2003). J. Pharmacol. Exp. Ther., 306, 838–845.

  • Price DJ, Miralem T, Jiang S, Steinberg R and Avraham H . (2001). Cell Growth Differ., 12, 129–135.

  • Ryden L, Linderholm B, Nielsen NH, Emdin S, Jonsson PE and Landberg G . (2003). Breast Cancer Res. Treat., 82, 147–154.

  • Shaheen RM, Tseng WW, Vellagas R, Liu W, Ahmad SA, Jung YD, Reinmuth N, Drazan KE, Bucana CD, Hicklin DJ and Ellis LM . (2001). Int. J. Oncol., 18, 221–226.

  • Stoeltzing O, Liu W, Reinmuth N, Parikh A, Ahmad SA, Jung YD, Fan F and Ellis LM . (2003). Ann. Surg. Oncol., 10, 722–733.

  • Takahashi T, Ueno H and Shibuya M . (1999). Oncogene, 18, 2221–2230.

  • von Marschall Z, Cramer T, Hocker M, Burde R, Plath T, Schirner M, Heidenreich R, Breier G, Riecken EO, Wiedenmann B and Rosewicz S . (2000). Gastroenterology, 119, 1358–1372.

  • Waltenberger J, Claesson-Welsh L, Siegbahn A, Shibuya M and Heldin CH . (1994). J. Biol. Chem., 269, 26988–26995.

  • Zhukova LG, Zhukov NV and Lichinitser MR . (2003). Bull. Exp. Biol. Med., 135, 478–481.

Download references

Acknowledgements

We thank Christine Wogan from the Department of Scientific Publications and Rita Hernandez from the Department of Surgical Oncology for editorial assistance. This work was supported by the Jon and Suzie Hall Fund for Colon Cancer Research (LME), NIH T32 grant (JSW, TWB), NIH CA112390 (LME) and NIH CCSG CA16672.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lee M Ellis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fan, F., Wey, J., McCarty, M. et al. Expression and function of vascular endothelial growth factor receptor-1 on human colorectal cancer cells. Oncogene 24, 2647–2653 (2005). https://doi.org/10.1038/sj.onc.1208246

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1208246

Keywords

This article is cited by

Search

Quick links